title: [Yellow fever].
abstract: Yellow fever is a mosquito born viral illness that causes hemorrhagic fever in tropical Africa and South America. An estimated 200 000 people are still infected annually. There is no antiviral therapy available and vaccination is major strategy in the control yellow fever. From 60 years ago is available very safe and efficient vaccine. The vaccine is a live attenuated virus strain 17D. Recently identified vaccine associated viscerotropic diseases (YFV-AVD). This paper describes knowledge about yellow fever disease, vaccine associated adverse events and actually recommendation for vaccine use.
authors.affiliation: Klinika Obserwacyjno-Zakaźna Akademii Medycznej w Białymstoku.
authors.forename: Alicja
authors.initials: A
authors.lastname: Wiercińska-Drapało
mesh_terms: D002489:Central America; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D032541:Mass Vaccination / Q000592:standards*; D013020:South America; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects; D015004:Yellow Fever / Q000276:immunology / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D014613:Vaccines, Attenuated; D022341:Yellow Fever Vaccine